定制脂质纳米颗粒用于T细胞向过敏性喘:对疗效和特异性的洞察
David C Jürgens1, Joschka T Müller1, Anny Nguyen1
1Department of Pharmacy, Ludwig-Maximilians-University Munich, Butenandtstrasse 5-13, Haus B, 81377 Munich, Germany.
研究人员开发了向性脂质纳米颗粒 (LNP) 用于过敏喘治疗. 这些LNP将siRNA传递给T细胞,达到50%以上的GATA3基因淘汰,显示出免疫性疾病治疗的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 过敏性喘影响全球超过3亿人,涉及Th2细胞细胞因子和呼吸道炎症.
- 需要有针对性的输送系统来提高喘治疗的疗效.
- 脂质纳米颗粒 (LNP) 提供了肺部药物输送的潜力.
研究的目的:
- 为了设计转移素受体向的LNP,以便siRNA传递给T细胞.
- 评估这些向LNP在减少与过敏性喘相关的基因表达中的有效性.
- 评估针对性LNP的肺输送的可行性.
主要方法:
- 使用SPAAC. 在LNP中将转激素连接物与PEGylated脂质结合.
- 使用纳米粒子追踪分析 (NTA) 进行LNP的表征.
- 通过ELISA对转激素结合的量化和细胞吸收和基因淘汰 (GATA3) 的评估在体外和体外.
主要成果:
- 创建了适合肺部输送的工程LNP.
- 证实转移素介导的细胞吸收是依赖于连接体的.
- 在相关模型中实现了50%以上的GATA3淘汰,证明了有效的基因沉默.
结论:
- 向的LNP可以有效地将siRNA传递给T细胞,用于潜在的过敏喘治疗.
- 干介导向增强细胞吸收和基因淘汰.
- 需要进一步优化LNP表面修饰,以提高针对免疫性疾病的准能力.
更多相关视频
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Dose-Response Relationship: Selectivity and Specificity
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
